CVR number 41627107
Industry 47.7400 Retail sale of medical and orthopaedic goods in specialised stores

Levitate Technology ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 8.1% 10.2% 2.8%  
Credit score (0-100)  0 0 29 23 58  
Credit rating  N/A N/A BB BB BBB  
Credit limit (kDKK)  0.0 397.8 0.0 -0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Net sales  0 0 0 0 0  
Gross profit  0.0 -217 -848 128 3,397  
EBITDA  0.0 -500 -1,874 -1,873 598  
EBIT  0.0 -500 -1,893 -2,248 -483  
Pre-tax profit (PTP)  0.0 -606.4 -2,208.3 -2,460.6 -549.6  
Net earnings  0.0 -453.9 -2,150.2 -2,349.2 -439.6  
Pre-tax profit without non-rec. items  0.0 -606 -2,208 -2,461 -550  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Tangible assets total  0.0 0.0 52.1 73.9 203  
Shareholders equity total  0.0 2,253 2,076 76.4 13,078  
Interest-bearing liabilities  0.0 2,055 2,219 2,397 0.0  
Balance sheet total (assets)  0.0 4,506 4,498 2,914 14,109  
Net Debt  0.0 -1,810 -778 1,808 -9,083  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -217 -848 128 3,397  
Gross profit growth  0.0% 0.0% -290.3% 0.0% 2,548.7%  
Employees  0 4 4 5 7  
Employee growth %  0.0% 0.0% 0.0% 25.0% 40.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 4,506 4,498 2,914 14,109  
Balance sheet change%  0.0% 0.0% -0.2% -35.2% 384.2%  
Added value  0.0 -500.4 -1,873.8 -2,228.8 597.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 316 674 -6 -685  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 230.4% 223.3% -1,752.6% -14.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% -11.1% -42.0% -60.5% -5.2%  
ROI %  0.0% -11.6% -44.0% -66.3% -5.7%  
ROE %  0.0% -20.1% -99.3% -218.3% -6.7%  

Solidity 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Equity ratio %  0.0% 50.5% 46.1% 2.6% 94.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 361.7% 41.5% -96.5% -1,519.7%  
Gearing %  0.0% 91.2% 106.9% 3,137.3% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 10.3% 14.8% 9.4% 8.8%  

Liquidity 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Quick Ratio  0.0 26.9 16.4 0.4 12.9  
Current Ratio  0.0 21.3 17.2 0.5 11.7  
Cash and cash equivalent  0.0 3,865.0 2,997.8 589.1 9,083.2  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 3,992.2 3,285.7 -1,302.2 10,982.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2022/3
2022
2023/3
2023
2024/3
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -125 -468 -446 85  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -125 -468 -375 85  
EBIT / employee  0 -125 -473 -450 -69  
Net earnings / employee  0 -113 -538 -470 -63